Analysis of Methylome, Transcriptome, and Lipid Metabolites to Understand the Molecular Abnormalities in Polycystic Ovary Syndrome

References

• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–2749. doi:10.1210/jc.2003-032046
   PubMed Web of Science ®Google Scholar
• Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–680. doi:10.1016/s2213-8587(22)00163-2
   PubMed Web of Science ®Google Scholar
• Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. doi:10.1016/j.fertnstert.2016.05.003
   PubMed Web of Science ®Google Scholar
• Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940. doi:10.1016/j.lfs.2019.116940
   PubMed Web of Science ®Google Scholar
• Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104. doi:10.1186/s12967-020-02277-0
   PubMed Web of Science ®Google Scholar
• Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics. 2015;70(11):765–769. doi:10.6061/clinics/2015(11)09
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Patel J, Jain NK, Joshi R. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14(1):125. doi:10.1186/s13048-021-00879-w
   PubMed Web of Science ®Google Scholar
• Tu J, Cheung AH, Chan CL, Chan WY. The Role of microRNAs in Ovarian Granulosa Cells in Health and Disease. Front Endocrinol. 2019;10:174. doi:10.3389/fendo.2019.00174
   PubMed Web of Science ®Google Scholar
• Huang Z, Wells D. The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. Mol Hum Reprod. 2010;16(10):715–725. doi:10.1093/molehr/gaq031
   PubMed Web of Science ®Google Scholar
• Tan M, Cheng Y, Zhong X, et al. LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway. Aging. 2021;13(3):4617–4633. doi:10.18632/aging.202421
   PubMedGoogle Scholar
• Kanbour SA, Dobs AS. Hyperandrogenism in Women with Polycystic Ovarian Syndrome: pathophysiology and Controversies. Clin Res Therapeutics. 2022;3(1):22–30. doi:10.1089/andro.2021.0020
   Google Scholar
• Rodriguez paris V, Bertoldo MJ. The Mechanism of Androgen Actions in PCOS Etiology. Med Sci. 2019;7(9):56.
   Google Scholar
• Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38. doi:10.1038/npp.2012.112
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6(8):597–610. doi:10.1038/nrg1655
   PubMed Web of Science ®Google Scholar
• Vázquez-Martínez ER, Gómez-Viais YI, García-Gómez E, et al. DNA methylation in the pathogenesis of polycystic ovary syndrome. Reproduction. 2019;158(1):R27–r40. doi:10.1530/rep-18-0449
   PubMed Web of Science ®Google Scholar
• Wang XX, Wei JZ, Jiao J. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget. 2014;5(16):6603–6610. doi:10.18632/oncotarget.2224
   PubMedGoogle Scholar
• Li S, Zhu D, Duan H, et al. Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women. Oncotarget. 2017;8(13):20656–20666. doi:10.18632/oncotarget.9327
   PubMedGoogle Scholar
• Divoux A, Erdos E, Whytock K, Osborne TF, Smith SR. Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women. Cells. 2022;11(5):46.
   Web of Science ®Google Scholar
• Rotterdam. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47. doi:10.1093/humrep/deh098
   PubMed Web of Science ®Google Scholar
• Mao Z, Li T, Zhao H, Wang X, Kang Y, Kang Y. Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome. J Cell Physiol. 2021;236(9):6362–6375. doi:10.1002/jcp.30309
   PubMed Web of Science ®Google Scholar
• Qin Y, Li T, Zhao H, Mao Z, Ding C, Kang Y. Integrated Transcriptomic and Epigenetic Study of PCOS: impact of Map3k1 and Map1lc3a Promoter Methylation on Autophagy. Front Genet. 2021;12:620241. doi:10.3389/fgene.2021.620241
   PubMed Web of Science ®Google Scholar
• Saadia Z. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women. Med Arch. 2020;74(4):289–293. doi:10.5455/medarh.2020.74.289-293
   PubMedGoogle Scholar
• Mitrašinović-Brulić M, Buljan M, Suljević D. Association of LH/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome. Middle East Fertility Society Journal. 2021;26(1):1–9.
   PubMed Web of Science ®Google Scholar
• Shen Y, Chow J, Wang Z, Fan G. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet. 2006;15(17):2623–2635. doi:10.1093/hmg/ddl188
   PubMed Web of Science ®Google Scholar
• Long MD, Smiraglia DJ, Campbell MJ. The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer. Biomolecules. 2017;7(1):68.
   PubMed Web of Science ®Google Scholar
• Lauretta R, Lanzolla G, Vici P, Mariani L, Moretti C, Appetecchia M. Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk. Int J Endocrinol. 2016;2016:1–17. doi:10.1155/2016/8671762
   Web of Science ®Google Scholar
• Sun L, Zhang Q, Li Q, et al. A novel PIK3R1 mutation of SHORT syndrome in a Chinese female with diffuse thyroid disease: a case report and review of literature. BMC Med Genet. 2020;21(1):215. doi:10.1186/s12881-020-01146-3
   PubMed Web of Science ®Google Scholar
• Dong F, Deng D, Chen H, et al. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem. 2015;407(16):4683–4695. doi:10.1007/s00216-015-8670-x
   PubMed Web of Science ®Google Scholar
• Hestiantoro A, Karimah PD, Shadrina A, Wiweko B, Muharam R, Astuti BPK. Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS. F1000Res. 2019;8:94. doi:10.12688/f1000research.16815.1
   PubMedGoogle Scholar
• Yu Z, Qin E, Cheng S, et al. Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study. Sci Rep. 2022;12(1):22184. doi:10.1038/s41598-022-25041-4
   PubMed Web of Science ®Google Scholar
• Li S, Zhu D, Duan H, Tan Q. The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations. Gynecological Endocrinol. 2016;32(12):942–946. doi:10.1080/09513590.2016.1203409
   PubMed Web of Science ®Google Scholar
• Haoula Z, Ravipati S, Stekel DJ, et al. Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics. 2015;11(3):657–666. doi:10.1007/s11306-014-0726-y
   PubMed Web of Science ®Google Scholar
• Liu L, He D, Wang Y, Sheng M. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome. Mol Med Rep. 2020;21(5):2138–2150. doi:10.3892/mmr.2020.11005
   PubMed Web of Science ®Google Scholar
• Pan JX, Tan YJ, Wang FF, et al. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis. Clin Epigenetics. 2018;10:6. doi:10.1186/s13148-018-0442-y
   PubMed Web of Science ®Google Scholar
• Liu YN, Qin Y, Wu B, et al. DNA methylation in polycystic ovary syndrome: emerging evidence and challenges. Reprod Toxicol. 2022;111:11–19. doi:10.1016/j.reprotox.2022.04.010
   PubMed Web of Science ®Google Scholar
• Crespo RP, Rocha TP, Montenegro LR, et al. High-throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort. J Endocr Soc. 2022;6(9):bvac106. doi:10.1210/jendso/bvac106
   PubMed Web of Science ®Google Scholar
• Yin X, Liu J, Feng R, Xu M, Liu J. Novel PIK3R1 mutation of SHORT syndrome: a case report with a 6-month follow up. J Diabetes Investig. 2021;12(10):1919–1922. doi:10.1111/jdi.13549
   PubMed Web of Science ®Google Scholar
• Kwok A, Zvetkova I, Virtue S, et al. C-Terminal Truncation of Pik3r1 in Mice Models Human Lipodystrophic Insulin Resistance Uncoupled from Dyslipidemia. Cold Spring Harbor Laboratory; 2017.
   Google Scholar
• Li S, Gao Y, Ma K, et al. Lipid-related protein NECTIN2 is an important marker in the progression of carotid atherosclerosis: an intersection of clinical and basic studies. J Transl Int Med. 2021;9(4):294–306. doi:10.2478/jtim-2021-0044
   PubMed Web of Science ®Google Scholar
• Jabbour R, Ott J, Eppel W, Frigo P. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLoS One. 2020;15(4):e0232299. doi:10.1371/journal.pone.0232299
   PubMed Web of Science ®Google Scholar
• Lauretta R, Lanzolla G, Vici P, Mariani L, Moretti C, Appetecchia M. Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk. Int J Endocrinol. 2016;2016:8671762. doi:10.1155/2016/8671762
   PubMed Web of Science ®Google Scholar
• Katzendorn O, Peters I, Dubrowinskaja N, et al. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers. BMC Cancer. 2021;21(1):444. doi:10.1186/s12885-021-08172-1
   PubMed Web of Science ®Google Scholar
• Bignotti E, Todeschini P, Calza S, et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer. 2010;46(5):944–953. doi:10.1016/j.ejca.2009.12.019
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999;84(6):1897–1899. doi:10.1210/jcem.84.6.5803
   PubMed Web of Science ®Google Scholar
• Zhu JL, Chen Z, Feng WJ, Long SL, Mo ZC. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 2019;499:142–148. doi:10.1016/j.cca.2019.09.010
   PubMed Web of Science ®Google Scholar
• Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci. 2008;65(16):2493–2506. doi:10.1007/s00018-008-8030-5
   PubMed Web of Science ®Google Scholar
• Zhang L, Bell RJ, Kiebish MA, et al. A mathematical model for the determination of steady-state cardiolipin remodeling mechanisms using lipidomic data. PLoS One. 2011;6(6):e21170. doi:10.1371/journal.pone.0021170
   PubMed Web of Science ®Google Scholar
• Zhang L, Hu Y, An Y, Wang Q, Liu J, Wang G. The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes. Front Endocrinol (Lausanne). 2022;13:677202. doi:10.3389/fendo.2022.677202
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584. doi:10.1056/NEJMoa1109400
   PubMed Web of Science ®Google Scholar
• Wang B, Tontonoz P. Phospholipid Remodeling in Physiology and Disease. Annu Rev Physiol. 2019;81:165–188. doi:10.1146/annurev-physiol-020518-114444
   PubMed Web of Science ®Google Scholar
• Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology. 2012;56(1):118–129. doi:10.1002/hep.25630
   PubMed Web of Science ®Google Scholar
• Yao Q, Zou X, Liu S, Wu H, Shen Q, Kang J. Oxidative Stress as a Contributor to Insulin Resistance in the Skeletal Muscles of Mice with Polycystic Ovary Syndrome. Int J Mol Sci. 2022;23:19.
   Web of Science ®Google Scholar
• Lucki NC, Sewer MB. The interplay between bioactive sphingolipids and steroid hormones. Steroids. 2010;75(6):390–399. doi:10.1016/j.steroids.2010.01.020
   PubMed Web of Science ®Google Scholar
• Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010;122(1–3):42–52. doi:10.1016/j.jsbmb.2009.12.010
   PubMed Web of Science ®Google Scholar
• Chen X, Lu T, Wang X, et al. Metabolic alterations associated with polycystic ovary syndrome: a UPLC Q-Exactive based metabolomic study. Clin Chim Acta. 2020;502:280–286. doi:10.1016/j.cca.2019.11.016
   PubMed Web of Science ®Google Scholar
• Ban Y, Ran H, Chen Y, Ma L. Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study. J Ovarian Res. 2021;14(1):135. doi:10.1186/s13048-021-00885-y
   PubMed Web of Science ®Google Scholar
• Liu Q, Xie YJ, Qu LH, Zhang MX, Mo ZC. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58(4):447–453. doi:10.1016/j.tjog.2019.05.003
   PubMed Web of Science ®Google Scholar
• Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017;107(6):1380–1386.e1. doi:10.1016/j.fertnstert.2017.04.011
   PubMed Web of Science ®Google Scholar
• Yang Z, Fu H, Su H, et al. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome. Front Microbiol. 2022;13:1017147. doi:10.3389/fmicb.2022.1017147
   PubMed Web of Science ®Google Scholar
• Zhao R, Jiang Y, Zhao S, Zhao H. Multiomics Analysis Reveals Molecular Abnormalities in Granulosa Cells of Women With Polycystic Ovary Syndrome. Front Genet. 2021;12:648701. doi:10.3389/fgene.2021.648701
   PubMed Web of Science ®Google Scholar